These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26296742)

  • 21. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adding protein to a carbohydrate supplement provided after endurance exercise enhances 4E-BP1 and RPS6 signaling in skeletal muscle.
    Morrison PJ; Hara D; Ding Z; Ivy JL
    J Appl Physiol (1985); 2008 Apr; 104(4):1029-36. PubMed ID: 18239077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex.
    Barone S; Zahedi K; Brooks M; Henske EP; Yang Y; Zhang E; Bissler JJ; Yu JJ; Soleimani M
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
    Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
    Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.
    Zhou J; Brugarolas J; Parada LF
    Hum Mol Genet; 2009 Nov; 18(22):4428-41. PubMed ID: 19692352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.
    Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT
    PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells.
    Wittenberg AD; Azar S; Klochendler A; Stolovich-Rain M; Avraham S; Birnbaum L; Binder Gallimidi A; Katz M; Dor Y; Meyuhas O
    PLoS One; 2016; 11(2):e0149995. PubMed ID: 26919188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.
    Ruvinsky I; Meyuhas O
    Trends Biochem Sci; 2006 Jun; 31(6):342-8. PubMed ID: 16679021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
    Kenerson HL; Aicher LD; True LD; Yeung RS
    Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker.
    Knoll M; Macher-Goeppinger S; Kopitz J; Duensing S; Pahernik S; Hohenfellner M; Schirmacher P; Roth W
    Oncotarget; 2016 Jan; 7(1):418-32. PubMed ID: 26506236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells.
    Bhandari BK; Feliers D; Duraisamy S; Stewart JL; Gingras AC; Abboud HE; Choudhury GG; Sonenberg N; Kasinath BS
    Kidney Int; 2001 Mar; 59(3):866-75. PubMed ID: 11231341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tsc1 ablation in Prx1 and Osterix lineages causes renal cystogenesis in mouse.
    Wu Z; Wu H; Md S; Yu G; Habib SL; Li B; Li J
    Sci Rep; 2019 Jan; 9(1):837. PubMed ID: 30696882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.
    Wilson C; Idziaszczyk S; Colley J; Humphreys V; Guy C; Maynard J; Sampson JR; Cheadle JP
    Cancer Res; 2005 Nov; 65(22):10179-82. PubMed ID: 16288003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas.
    Leech JD; Lammers SH; Goldman S; Auricchio N; Bronson RT; Kwiatkowski DJ; Sahin M
    Mol Cancer Res; 2015 Mar; 13(3):548-55. PubMed ID: 25548102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells.
    Senthil D; Choudhury GG; Abboud HE; Sonenberg N; Kasinath BS
    Am J Physiol Renal Physiol; 2002 Dec; 283(6):F1226-36. PubMed ID: 12388420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
    Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
    Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.